Technology

TAU Study Shows Tumors Reprogram Immune Cells

Published

The Tel Aviv University campus on March 15, 2021. Photo by Eitan Elhadez-Barak/TPS-IL.

Tel Aviv University reported July 2 that researchers at its Gray Faculty of Medical and Health Sciences developed Effero-seq, a tracking technology that shows how tumors can turn macrophages after they consume dead cancer cells. The TAU team, led by Dr. Merav Cohen with doctoral students Roi Balaban and Ori Moskowitz, found the reprogrammed immune cells help form blood vessels that nourish tumors and become less responsive to anti-cancer signals. The Science Immunology study also linked the signature in uveal melanoma patients to lower survival. Israeli medicine keeps turning basic science into possible therapies for patients worldwide.

Sources

Primary sources:1Secondary sources:234

Related stories

  1. Israeli Study Finds Inner-Ear Cells May Aid Hearing Regeneration
  2. TAU 3D Sperm Imaging Method Boosts IVF Selection Accuracy
  3. Teva Advances Vitiligo Antibody to Phase 2b After Results
  4. Israeli Vets Warn Animal-Eye Superbugs Can Spread to Humans
  5. Health Ministry Reports Hospital Infection Decline

Something went wrong

We couldn't complete that action. Check your connection and try again.